Atlas Trials

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Clinical trial NCT03852407 · RECRUITING

Trial details

NCT number
NCT03852407
Sponsor
University of Liege
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in RemissionMyeloproliferative SyndromeMyeloproliferative DisorderAcute Lymphoid Leukemia in RemissionMultiple MyelomaChronic Lymphoid LeukemiaNon Hodgkin LymphomaHodgkin Lymphoma
Start date
2019-02-04
Primary completion
2033-11-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.